MODIFICATION
A -- Reagent Generation for Bioanalytical Method Development for Biologics - Amendment 2
- Notice Date
- 12/7/2017
- Notice Type
- Modification/Amendment
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211, MSC 9559, Bethesda, Maryland, 20892-9559, United States
- ZIP Code
- 20892-9559
- Solicitation Number
- N01TR-18-2006
- Response Due
- 12/15/2017 3:00:00 PM
- Point of Contact
- Stuart G. Kern, Phone: 3014023334, Jeffrey Schmidt, Phone: (301) 402-1488
- E-Mail Address
-
stuart.kern@nih.gov, schmidtjr@mail.nih.gov
(stuart.kern@nih.gov, schmidtjr@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Modification No. 2 clarifies the role of GMP in this solicitation. This notice amends the solicitation to confirm that the development of bioanalytical assay reagents under this solicitation is a non-GLP/non-GMP activity (as stated in Attachment 3, Statement of Work), and removes the requirement in the Sample Task Order Request for Proposal (TORPF) (Attachment 4) that respondents show that facilities are appropriate for handling drug products under cGMPs.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/N01TR-18-2006/listing.html)
- Place of Performance
- Address: National Center for Advancing Translational Sciences, 9800 Medical Center Drive, Rockville, Maryland, 20850, United States
- Zip Code: 20850
- Zip Code: 20850
- Record
- SN04760018-W 20171209/171207231035-8818ef556785ab59195261fafb8251f1 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |